who we are

health biotechnology

Ebiotec is the Biotechnological Center of the Euroespes Group where exclusive nutraceutical bioproducts are manufactured for national and international distribution.

The health contributions of nutraceutical products have attracted the attention of medical professionals and human health researchers. The development of active ingredients of natural origin has progressed strongly in recent decades and Ebiotec's vocation for research and innovation has positioned us as one of the leading companies in this field at international level.

Our commitment to society is to put knowledge and biotechnology at the service of people's well-being.


Our nutraceutical bioproducts are developed through a unique non-denaturing biotechnological process, so that they retain all the biological properties of their natural source.


Ebiotec's bioproducts are derived from marine species (LIPOPHYSINS AND PROTEOLIPINS), plant species (FAVALINS), a hybrid line, and an animal line under development.

  • 100% natural ingredients that keep all bioactive properties intact.
  • 100% Spanish technology and production in the biotechnology plant located in Galicia.
  • More than two decades of experience and satisfied consumers.
  • Active ingredients derived from marine species (lipophysins and proteolipins) and vegetable species (podofavalins).
  • Functionally complex nutraceuticals in which the synergic action of their components increases their efficacy.
  • Nutraceuticals with the highest international quality international quality standards.
  • Non GMO's, non-irradiated, gluten free, no additives added.


As pioneers in the area of applied science, we offer innovative services focused on improving diagnosis and therapeutic treatment.

  • Industrial lyophilization
  • Preclinical trials
  • Proteomic studies
  • Gene expression analysis
  • Development of customized R&D projects


international center for neurosciences and genomic medicine EUROESPES

Ebiotec is part of the EuroEspes Group (EuroEspes Health), a pioneer in the worldwide implementation of Personalized Medicine based on the genetics of each person.


  • Medical Center Specialized in the prevention, early diagnosis and treatment of diseases of the central nervous system (Alzheimer, Parkinson, Dementias), cerebrovascular (stroke), neuropsychiatric (personality disorders, depression, schizophrenia, ...), etc...
  • Clinical analysis laboratory (Covid -19, Biopanels, Tumor markers, etc.)
  • Predictive genetics: Development of specific panels that assess the genetic risk of developing multiple pathologies.
  • Pharmacogenetics: world leaders in the implementation of personalized pharmacogenetics as the most effective pharmacological treatment strategy, avoiding toxic reactions to drugs.
  • Health biotechnology: Development of natural bioproducts from research processes and own studies.